Coronavirus death rate far higher for black Caribbean people

Coronavirus is killing black Caribbean people in hospitals in England at almost three times the rate of white people, highlighting inequalities in the deadly effects of the disease.

Experts said that unlike in the US, the higher mortality rate, especially for those of black Caribbean descent, was not simply because the victims were more likely to live in areas where the virus was most prevalent.

The figures and analysis will reinforce concerns that Covid-19 has exposed deep disparities in British society, with some ethnic minority groups facing choices between their lives and their livelihoods.

Figures from NHS England on Thursday showed the disproportionate pain the coronavirus has inflicted on black Caribbean people — far greater than on other large ethnic minority groups or on white people.

Data running up to April 28 showed that the virus had killed 33 white people per 100,000 in English hospitals, but had killed 89

Read More

Amazon sees possible second-quarter loss as it forecasts $4 billion in COVID-19-related costs

(Reuters) – Inc (AMZN.O) on Thursday said it could post its first quarterly loss in five years because it is spending at least $4 billion in response to the coronavirus pandemic, including plans to test its workers for COVID-19, providing staff with protective gear and raising hourly wages.

FILE PHOTO: The logo of Amazon is seen at the company logistics center in Lauwin-Planque, northern France, April 22, 2020 after Amazon extended the closure of its French warehouses until April 25 included, following dispute with unions over health protection measures amid the coronavirus disease (COVID-19) outbreak. REUTERS/Pascal Rossignol

Shares of Amazon, the world’s largest online retailer, fell 5% in after-hours trade.

Online retailers have seen demand spike to levels more typical of the winter holiday season as governments around the world have ordered people indoors in efforts to contain the spread of the virus. Amazon has been at

Read More

Boeing set to raise $25 billion in massive debt sale – sources

(Reuters) – Boeing Co (BA.N) expects to raise around $25 billion (19.9 billion pounds) in its bond offering on Thursday, according to people familiar with the matter, a blowout result for the planemaker shoring up its finances during the coronavirus-induced travel downturn.

FILE PHOTO: Boeing’s Everett factory outside Seattle is pictured after a worker there who had the coronavirus died, the Seattle Times reported on Sunday, as efforts continue to help slow the spread of coronavirus disease (COVID-19) in Everett, Washington, U.S. March 22, 2020. REUTERS/Jason Redmond

Boeing’s capital raise, first reported by Reuters earlier this week, would be the sixth-largest investment-grade bond offering of all time and the biggest year-to-date, according to Refinitiv data. The Federal Reserve’s intervention in the credit market has boosted prospects for troubled borrowers such as Boeing.

The U.S. central bank has slashed interest rates to zero and rolled out around $2 trillion

Read More

Gilead aims to expand remdesivir output for COVID-19, posts flat first-quarter results

(Reuters) – Gilead Sciences Inc (GILD.O), maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake

The company said it still expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to produce several million treatment courses in 2021.”

By the end of next month, Gilead said it should have manufactured more than 140,000 treatment courses of the drug that is given by infusion in the hospital.

Gilead also reported flat first-quarter earnings and its shares fell 2% in extended

Read More